|
1
|
Machlowska J, Baj J, Sitarz M, Maciejewski
R and Sitarz R: Gastric cancer: Epidemiology, risk factors,
classification, genomic characteristics and treatment strategies.
Int J Mol Sci. 21:40122020. View Article : Google Scholar :
|
|
2
|
Wong MCS, Huang J, Chan PSF, Choi P, Lao
XQ, Chan SM, Teoh A and Liang P: Global incidence and mortality of
gastric cancer, 1980-2018. JAMA Netw Open. 4:e21184572021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Joshi SS and Badgwell BD: Current
treatment and recent progress in gastric cancer. CA Cancer J Clin.
71:264–279. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Camby I, Le Mercier M, Lefranc F and Kiss
R: Galectin-1: A small protein with major functions. Glycobiology.
16:137R–157R. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carlini MJ, Roitman P, Nuñez M, Pallotta
MG, Boggio G, Smith D, Salatino M, Joffé ED, Rabinovich GA and
Puricelli LI: Clinical relevance of galectin-1 expression in
non-small cell lung cancer patients. Lung Cancer. 84:73–78. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang CS, Tang SJ, Chung LY, Yu CP, Ho JY,
Cha TL, Hsieh CC, Wang HH, Sun GH and Sun KH: Galectin-1
upregulates CXCR4 to promote tumor progression and poor outcome in
kidney cancer. J Am Soc Nephrol. 25:1486–1495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang PF, Li KS, Shen YH, Gao PT, Dong ZR,
Cai JB, Zhang C, Huang XY, Tian MX, Hu ZQ, et al: Galectin-1
induces hepatocellular carcinoma EMT and sorafenib resistance by
activating FAK/PI3K/AKT signaling. Cell Death Dis. 7:e22012016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schulz H, Schmoeckel E, Kuhn C, Hofmann S,
Mayr D, Mahner S and Jeschke U: Galectins-1, -3, and -7 are
prognostic markers for survival of ovarian cancer patients. Int J
Mol Sci. 18:12302017. View Article : Google Scholar :
|
|
9
|
Elola MT, Wolfenstein-Todel C, Troncoso
MF, Vasta GR and Rabinovich GA: Galectins: Matricellular
glycan-binding proteins linking cell adhesion, migration, and
survival. Cell Mol Life Sci. 64:1679–1700. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boyce M and Yuan J: Cellular response to
endoplasmic reticulum stress: A matter of life or death. Cell Death
Differ. 13:363–373. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hetz C: The unfolded protein response:
Controlling cell fate decisions under ER stress and beyond. Nat Rev
Mol Cell Biol. 13:89–102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo B and Lee AS: The critical roles of
endoplasmic reticulum chaperones and unfolded protein response in
tumorigenesis and anticancer therapies. Oncogene. 32:805–818. 2013.
View Article : Google Scholar
|
|
13
|
Ibrahim IM, Abdelmalek DH and Elfiky AA:
GRP78: A cell's response to stress. Life Sci. 226:156–163. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cook KL, Soto-Pantoja DR, Clarke PA, Cruz
MI, Zwart A, Wärri A, Hilakivi-Clarke L, Roberts DD and Clarke R:
Endoplasmic reticulum stress protein GRP78 modulates lipid
metabolism to control drug sensitivity and antitumor immunity in
breast cancer. Cancer Res. 76:5657–5670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Serrano-Negrón JE, Zhang Z, Rivera-Ruiz
AP, Banerjee A, Romero-Nutz EC, Sánchez-Torres N, Baksi K and
Banerjee DK: Tunicamycin-induced ER stress in breast cancer cells
neither expresses GRP78 on the surface nor secretes it into the
media. Glycobiology. 29:5992019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahmadi A, Khansarinejad B, Hosseinkhani S,
Ghanei M and Mowla SJ: miR-199a-5p and miR-495 target GRP78 within
UPR pathway of lung cancer. Gene. 620:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao G, Kang J, Xu G, Wei J, Wang X, Jing
X, Zhang L, Yang A, Wang K, Wang J, et al: Tunicamycin promotes
metastasis through upregulating endoplasmic reticulum stress
induced GRP78 expression in thyroid carcinoma. Cell Biosci.
10:1152020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chern YJ, Wong JCT, Cheng GSW, Yu A, Yin
Y, Schaeffer DF, Kennecke HF, Morin G and Tai IT: The interaction
between SPARC and GRP78 interferes with ER stress signaling and
potentiates apoptosis via PERK/eIF2α and IRE1α/XBP-1 in colorectal
cancer. Cell Death Dis. 10:5042019. View Article : Google Scholar
|
|
19
|
Luo C, Xiong H, Chen L, Liu X, Zou S, Guan
J and Wang K: GRP78 promotes hepatocellular carcinoma proliferation
by increasing FAT10 expression through the NF-κB pathway. Exp Cell
Res. 365:1–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Zhang Y, Lin F, Shi X, Xiang L
and Li L: Shh overexpression is correlated with GRP78 and AR
expression in primary prostate cancer: Clinicopathological features
and outcomes in a Chinese cohort. Cancer Manag Res. 12:1569–1578.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ogawa H, Kaira K, Takahashi K, Shimizu A,
Altan B, Yoshinari D, Asao T and Oyama T: Prognostic role of
BiP/GRP78 expression as ER stress in patients with gastric
adenocarcinoma. Cancer Biomark. 20:273–281. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45(W1):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oughtred R, Rust J, Chang C, Breitkreutz
BJ, Stark C, Willems A, Boucher L, Leung G, Kolas N, Zhang F, et
al: The BioGRID database: A comprehensive biomedical resource of
curated protein, genetic, and chemical interactions. Protein Sci.
30:187–200. 2021. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
MacArthur Clark JA and Sun D: Guidelines
for the ethical review of laboratory animal welfare People's
Republic of China national standard GB/T 35892-2018[Issued 6
February 2018 effective from 1 September 2018. Animal Model Exp
Med. 3:103–113. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fang S, Hong H, Li L, He D, Xu Z, Zuo S,
Han J, Wu Q, Dai Z, Cai W, et al: Plasminogen kringle 5 suppresses
gastric cancer via regulating HIF-1α and GRP78. Cell Death Dis.
8:e31442017. View Article : Google Scholar
|
|
28
|
Fu Z, Wang X, Zhou H, Li Y, Chen Y, Wang Z
and Liu L: GRP78 positively regulates estrogen-stimulated cell
growth mediated by ER-α36 in gastric cancer cells. Mol Med Rep.
16:8329–8334. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kong Q, Zhang Z and Liang Z: Upregulating
miR-637 aggravates endoplasmic reticulum stress-induced apoptosis
in gastric cancer cells by suppressing calreticulin. Anim Cells
Syst (Seoul). 24:267–274. 2020. View Article : Google Scholar
|
|
30
|
You X, Wang Y, Wu J, Liu Q, Chen D, Tang D
and Wang D: Prognostic significance of galectin-1 and vasculogenic
mimicry in patients with gastric cancer. Onco Targets Ther.
11:3237–3244. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
You X, Wu J, Wang Y, Liu Q, Cheng Z, Zhao
X, Liu G, Huang C, Dai J, Zhou Y, et al: Galectin-1 promotes
vasculogenic mimicry in gastric adenocarcinoma via the Hedgehog/GLI
signaling pathway. Aging (Albany NY). 12:21837–21853. 2020.
View Article : Google Scholar
|
|
32
|
Nambiar DK, Aguilera T, Cao H, Kwok S,
Kong C, Bloomstein J, Wang Z, Rangan VS, Jiang D, von Eyben R, et
al: Galectin-1-driven T cell exclusion in the tumor endothelium
promotes immunotherapy resistance. J Clin Invest. 129:5553–5567.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He YS, Hu YQ, Xiang K, Chen Y, Feng YT,
Yin KJ, Huang JX, Wang J, Wu ZD, Wang GH and Pan HF: Therapeutic
potential of galectin-1 and galectin-3 in autoimmune diseases. Curr
Pharm Des. 28:36–45. 2022. View Article : Google Scholar
|
|
34
|
Arciniegas E, Carrillo LM, Rojas H, Pineda
J, Ramírez R, Reyes O, Chopite M and Rocheta A: Plump endothelial
cells integrated into pre-existing venules contribute to the
formation of 'mother' and 'daughter' vessels in pyogenic granuloma:
Possible role of galectin-1, -3 and -8. Scars Burn Heal.
7:20595131209866872021.PubMed/NCBI
|
|
35
|
Camby I, Belot N, Lefranc F, Sadeghi N, de
Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, et
al: Galectin-1 modulates human glioblastoma cell migration into the
brain through modifications to the actin cytoskeleton and levels of
expression of small GTPases. J Neuropathol Exp Neurol. 61:585–596.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kovács-Sólyom F, Blaskó A, Fajka-Boja R,
Katona RL, Végh L, Novák J, Szebeni GJ, Krenács L, Uher F, Tubak V,
et al: Mechanism of tumor cell-induced T-cell apoptosis mediated by
galectin-1. Immunol Lett. 127:108–118. 2010. View Article : Google Scholar
|
|
37
|
Horiguchi N, Arimoto K, Mizutani A,
Endo-Ichikawa Y, Nakada H and Taketani S: Galectin-1 induces cell
adhesion to the extracellular matrix and apoptosis of non-adherent
human colon cancer Colo201 cells. J Biochem. 134:869–874. 2003.
View Article : Google Scholar
|
|
38
|
Kim HJ, Jeon HK, Cho YJ, Park YA, Choi JJ,
Do IG, Song SY, Lee YY, Choi CH, Kim TJ, et al: High galectin-1
expression correlates with poor prognosis and is involved in
epithelial ovarian cancer proliferation and invasion. Eur J Cancer.
48:1914–1921. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Saussez S, Cucu DR, Decaestecker C,
Chevalier D, Kaltner H, André S, Wacreniez A, Toubeau G, Camby I,
Gabius HJ and Kiss R: Galectin 7 (p53-induced gene 1): A new
prognostic predictor of recurrence and survival in stage IV
hypopharyngeal cancer. Ann Surg Oncol. 13:999–1009. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chiang WF, Liu SY, Fang LY, Lin CN, Wu MH,
Chen YC, Chen YL and Jin YT: Overexpression of galectin-1 at the
tumor invasion front is associated with poor prognosis in
early-stage oral squamous cell carcinoma. Oral Oncol. 44:325–334.
2008. View Article : Google Scholar
|
|
41
|
Gao Y, Li X, Shu Z, Zhang K, Xue X, Li W,
Hao Q, Wang Z, Zhang W, Wang S, et al: Nuclear galectin-1-FOXP3
interaction dampens the tumor-suppressive properties of FOXP3 in
breast cancer. Cell Death Dis. 9:4162018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Leung Z, Ko FCF, Tey SK, Kwong EML, Mao X,
Liu BHM, Ma APY, Fung YME, Che CM, Wong DKH, et al: Galectin-1
promotes hepatocellular carcinoma and the combined therapeutic
effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells.
J Exp Clin Cancer Res. 38:4232019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pranjol MZI, Zinovkin DA, Maskell ART,
Stephens LJ, Achinovich SL, Los' DM, Nadyrov EA, Hannemann M,
Gutowski NJ and Whatmore JL: Cathepsin L-induced galectin-1 may act
as a proangiogenic factor in the metastasis of high-grade serous
carcinoma. J Transl Med. 17:2162019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kucińska M, Porębska N, Lampart A, Latko
M, Knapik A, Zakrzewska M, Otlewski J and Opaliński Ł: Differential
regulation of fibroblast growth factor receptor 1 trafficking and
function by extracellular galectins. Cell Commun Signal. 17:652019.
View Article : Google Scholar
|
|
45
|
Kuo LJ, Hung CS, Chen WY, Chang YJ and Wei
PL: Glucose-regulated protein 78 silencing down-regulates vascular
endothelial growth factor/vascular endothelial growth factor
receptor 2 pathway to suppress human colon cancer tumor growth. J
Surg Res. 185:264–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chang YJ, Chen WY, Huang CY, Liu HH and
Wei PL: Glucose-regulated protein 78 (GRP78) regulates colon cancer
metastasis through EMT biomarkers and the NRF-2/HO-1 pathway.
Tumour Biol. 36:1859–1869. 2015. View Article : Google Scholar
|
|
47
|
Yuan XP, Dong M, Li X and Zhou JP: GRP78
promotes the invasion of pancreatic cancer cells by FAK and JNK.
Mol Cell Biochem. 398:55–62. 2015. View Article : Google Scholar
|
|
48
|
Yin Y, Chen C, Chen J, Zhan R, Zhang Q, Xu
X, Li D and Li M: Cell surface GRP78 facilitates hepatoma cells
proliferation and migration by activating IGF-IR. Cell Signal.
35:154–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qian Y, Wong CC, Xu J, Chen H, Zhang Y,
Kang W, Wang H, Zhang L, Li W, Chu ESH, et al: Sodium channel
subunit SCNN1B suppresses gastric cancer growth and metastasis via
GRP78 degradation. Cancer Res. 77:1968–1982. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bastida-Ruiz D, Wuillemin C, Pederencino
A, Yaron M, Martinez de Tejada B, Pizzo SV and Cohen M: Activated
α2-macroglobulin binding to cell surface GRP78 induces
trophoblastic cell fusion. Sci Rep. 10:96662020. View Article : Google Scholar
|
